Related Experiment Videos
Organ- and tissue-specific stem cells and carcinogenesis
1Department of Cancer Biology, The University of Texas M. D. Anderson Cancer Center, Houston 77030, USA. spathak@notes.mdacc.Atmc.edu
Anticancer Research
|August 10, 2002
Summary
Cancers may originate from tissue-specific stem cells, which share many traits with cancer cells. Identifying these circulating stem cells could enable early cancer predisposition diagnosis and guide targeted drug development.
Area of Science:
- Oncology
- Stem Cell Biology
Background:
- Adult tissues contain stem cells with self-renewal and differentiation capabilities.
- Cancer cells exhibit similarities to tissue-specific stem cells, including proliferation, migration, and telomerase expression.
- Telomerase plays a crucial role in maintaining chromosome integrity.
Purpose of the Study:
- To propose that cancers arise from tissue-specific stem cells.
- To explore the potential for early cancer predisposition diagnosis through circulating stem cells.
- To suggest a new direction for cancer drug development targeting tissue-specific stem cells.
Main Methods:
- Comparative analysis of cancer cells and tissue-specific stem cells.
- Hypothesizing the origin of solid and hematopoietic cancers from tissue-specific stem cells.
- Investigating the presence of stem cells in peripheral blood of cancer patients and relatives.
Main Results:
- Cancer cells and tissue-specific stem cells share key biological characteristics.
- Tissue-specific stem cells are proposed as the origin of various cancers.
- Circulating stem cells with genetic defects may indicate cancer predisposition.
Conclusions:
- Cancers likely originate from tissue-specific stem cells.
- Detecting circulating stem cells could facilitate early diagnosis of cancer predisposition.
- Targeting tissue-specific stem cells is a promising strategy for cancer treatment development.